We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Genesis HealthCare to Sell Home & Hospice Operations

By HospiMedica International staff writers
Posted on 27 Mar 2016
Genesis HealthCare (Kennett Square, PA, USA) has signed an agreement to sell the majority of its home health and hospice operations to Compassus (Brentwood, TN, USA) for USD 84 million. More...


The Genesis home health and hospice operations included in the deal are located in the states of California, Idaho, Montana, and New Mexico; remaining hospice operations in Arizona and Nevada will be closed. The agreement is part of an ongoing strategic move launched by Genesis to monetize non-strategic assets, including the home health and hospice businesses, in order to repay debts. The strategy is expected to yield a cash flow income of USD 100–150 million, after tax.

The home health and hospice operations became part of Genesis HealthCare following its February 2015 merger with Skilled Healthcare, which created one of the largest post-acute care providers in the United States. The buyer, Compassus, is comprised of a nationwide network of community-based post-acute care services primarily focused on hospice, palliative, and home health care. The company opened its first hospice in 1979, and following the deal will operate more than 165 programs in 30 states.

“Home health and hospice services are non-strategic businesses for Genesis to operate at this time, and we believe we can better allocate the capital by de-levering our balance sheet,” said George Hager, Jr., CEO of Genesis HealthCare. “We are pleased that our home health and hospice businesses will join a respected, quality provider like Compassus.”

“We are excited to welcome Genesis’ home health and hospice businesses to the Compassus family, as we share very similar missions and values,” said James Deal, CEO of Compassus. “As Compassus continues to grow, this further strengthens our ability and desire to provide greater access to a continuum of high-quality post-acute care, including hospice, palliative, and home health care services to even more patients, families and the health care professionals who serve them.”

According to the Wall Street Journal (WSJ), the supersizing of the healthcare industry in the United States is a result of the Affordable Care Act, and reflects the efforts of providers to gain the scale necessary to succeed amid the changes unleashed or accelerated by the health law. Those include growing pressures to constrain costs and new forms of payment that require providers to meet efficiency and care-quality goals. The process has so far not been slowed down by the growing regulatory concern about health-care consolidation.

Related Links:

Genesis HealthCare
Compassus



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.